We report the use of centrally administered tissue-type plasminogen activator for three patients who presented with massive pulmonary embolism to the emergency department. In all patients, rapid improvement of pulmonary arterial pressures ensued by the end of the drug infusion, while the presenting
β¦ LIBER β¦
Feasibility of Tissue Plasminogen Activator Formulated for Pulmonary Delivery
β Scribed by John S. Dunn; Rajiv Nayar; Jackie Campos; Brooks M. Hybertson; Yue Zhou; Mark Cornell Manning; John E. Repine; Kathleen A. Stringer
- Publisher
- Springer US
- Year
- 2005
- Tongue
- English
- Weight
- 453 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0724-8741
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Treatment of massive pulmonary embolism
β
Subodh K Mohindra; George O Udeani
π
Article
π
1993
π
Elsevier Science
π
English
β 404 KB
Catheter-Directed Thrombolysis with Reco
β
A. Beitzke; G. Zobel; W. Zenz; A. Gamillscheg; J-I. Stein
π
Article
π
1996
π
Springer
π
English
β 350 KB
The use of recombinant tissue plasminoge
β
Andreas Wedrich; Rupert Menapace; Eva MΓΌhlbauer-Ries
π
Article
π
1995
π
Springer Netherlands
π
English
β 353 KB
Intraventricular administration of recom
β
Mete Akisu; Mehmet Yalaz; Sertac Arslanoglu; Nilgun Kultursay
π
Article
π
2003
π
Springer-Verlag
π
English
β 130 KB
Bronchoalveolar levels of plasminogen ac
β
Rogier M. Determann; Julian L. Millo; Chris S. Garrard; Marcus J. Schultz
π
Article
π
2006
π
Springer
π
English
β 86 KB
Characterization of indium-111 labeled r
β
D. J. Hnatowich; F. Virzi; P. W. Doherty; J. Wilson; J. Rosa; J. E. Ansell
π
Article
π
1987
π
Springer
π
English
β 708 KB
The in vitro functional properties of recombinant tissue plasminogen activator (rt-PA), its biodistribution in mice, and its pharmacokinetics and clot localization properties in dogs have been investigated after labeling rt-PA with 111In. The rt-PA was coupled with the bicyclic anhydride of DTPA usi